Zepp Health Corporation

NYSE:ZEPP

Consumer Electronics

Technology
$3.55 -0.58%

-$0.03 today

Market cap
$50.84M
Beta
1.78
P/E (TTM)
-0.1
EPS (TTM)
-$282.07
52W Low $2.36High $61.85

Volume 0.04M

Average 0.13M

ZEPP Change in Working Capital

Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.

Zepp Health CorporationNYSE: ZEPP

Change in Working Capital · Q4 FY2025 · quarter ended Dec 2025

Change in working capital turns negative

Q4 FY2025 change in working capital was -CN¥109.97M, compared with CN¥0 a year earlier. Trailing-twelve-month change in working capital was -CN¥109.97M. Over 3 fiscal years it compounded at +10.2% a year.

Context

  • Change in working capital amounted to 6.1% of revenue in FY2025, up 5.5 pp from a year earlier.
  • Change in working capital increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly change in working capital holds near -CN¥109.97M or moves back toward the trailing-twelve-month quarterly average of -CN¥27.49M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterDec 2025
-CN¥109.97M— QoQ
Last fiscal yearDec 2025
-CN¥109.97M-1535.1% YoY
LTMDec 2025
-CN¥109.97M— YoY
Change in Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-1535.1%——
3-year CAGR+10.2%——
5-year CAGR——
10-year CAGR——

Change in Working Capital history

CNY · from the cash flow

Latest · FY2025
(109.97M) CNY
Year-over-year change
-1535.1%

Change in Working Capital vs competitors

How ZEPP compares with its peers on the latest reported figures

  • Peers report in different currencies, so change in working capital is compared through growth and share of revenue rather than absolute size.
  • Change in working capital amounts to 6.0% of revenue for ZEPP, versus a peer median of 6.6%.
ZEPP Competitors
Change in Working Capital for ZEPP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ZEPPZepp Health CorporationLTM Dec 2025CN¥109.97M CNY—+10.2%6.0%
SVCOSilvaco Group, Inc. Common StockLTM Mar 2026$33.92M USD+187.7%—50.8%
TTECTTEC Holdings, Inc.LTM Mar 2026$24.69M USD+118.6%—1.2%
BWBabcock & Wilcox Enterprises, Inc.LTM Mar 2026$15.28M USD-65.4%-13.3%2.3%
TROOTROOPS, Inc.FY2025$14.96M USD+640.2%—87.5%
STEMStem, Inc.LTM Mar 2026$10.09M USD-58.1%—6.6%
KULRKULR Technology Group, Inc.LTM Mar 2026$8.46M USD-5.8%+35.2%45.6%
EXFYExpensify, Inc.LTM Mar 2026$903K USD+125.0%+110.4%0.6%
Peer median (excluding ZEPP) —+118.6%+35.2%6.6%

Competitors are the stored peer set for ZEPP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income136.02M(43.35M)(31.09M)(75.81M)(280.18M)
Depreciation & Amortization51.21M8.71M7.69M5.02M31.71M
Deferred Income Tax(18.45M)(9.92M)(2.88M)13.45M15.65M
Stock-Based Compensation07.27M8.79M4.78M17.43M
Change in Working Capital(620.52M)(82.26M)47.88M7.66M(109.97M)
Accounts Receivables300.79M3.13M43.8M404K(80.68M)
Inventory(82.05M)27.92M51.91M5.56M(154.48M)
Accounts Payables(664.51M)(135.34M)(27.82M)14.81M197.86M
Other Working Capital(174.76M)22.03M(20.02M)(13.11M)(72.67M)
Other Non-Cash Items119.98M2.44M12.21M20.51M145.71M
Operating Cash Flow(331.77M)(117.11M)42.6M(24.39M)(179.65M)
Capital Expenditures(45.46M)(1.47M)(1.68M)(1.49M)(5.48M)
Acquisitions (Net)35.99M60K427K00
Purchases of Investments(1.06B)(4.32M)(282K)(7M)0
Sales of Investments24.68M1.8M5.93M5.16M11.67M
Other Investing Activities0(2.57M)3.25M1.66M2.29M
Investing Cash Flow(1.06B)(6.24M)7.73M(1.58M)10.35M
Debt Repayment654.58M16.55M(46.98M)(1.65M)(51.29M)
Common Stock Issued5.39M0000
Common Stock Repurchased(13.58M)(8.16M)(2.52M)(2.28M)(8.66M)
Dividends Paid0(6.31M)000
Other Financing Activities040.28M7.82M4.4M233.61M
Financing Cash Flow646.39M42.37M(41.68M)477K173.66M
Effect of Forex Changes33.47M(14.77M)(9.31M)(4.24M)11.01M
Net Change in Cash(707.46M)(95.76M)(652K)(29.73M)15.37M
Free Cash Flow(377.22M)(118.59M)40.92M(25.88M)(185.14M)

Zepp Health Corporation

NYSE:ZEPP

Intrinsic Alpha fair value

Locked

Current Price

$3.55

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.